← Back to Screener
OrthoPediatrics Corp. Common Stock (KIDS)
Price$16.53
Favorite Metrics
Price vs S&P 500 (26W)-5.37%
Price vs S&P 500 (4W)1.32%
Market Capitalization$451.23M
All Metrics
Book Value / Share (Quarterly)$13.81
P/TBV (Annual)1.66x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)24.56%
Cash Flow / Share (Quarterly)$-0.64
Price vs S&P 500 (YTD)-2.14%
Gross Margin (TTM)73.05%
Net Profit Margin (TTM)-16.78%
EPS (TTM)$-1.69
10-Day Avg Trading Volume0.14M
EPS Excl Extra (TTM)$-1.69
Revenue Growth (5Y)27.16%
EPS (Annual)$-1.69
ROI (Annual)-8.88%
Gross Margin (Annual)73.05%
Net Profit Margin (5Y Avg)-12.98%
Cash / Share (Quarterly)$2.42
Revenue Growth QoQ (YoY)16.97%
ROA (Last FY)-7.80%
Revenue Growth TTM (YoY)15.45%
EBITD / Share (TTM)$-0.51
ROE (5Y Avg)-6.91%
Operating Margin (TTM)-16.60%
Cash Flow / Share (Annual)$-0.64
P/B Ratio1.30x
P/B Ratio (Quarterly)1.28x
Net Income / Employee (Annual)$-0
EV / Revenue (TTM)2.07x
Net Interest Coverage (TTM)-5.54x
ROA (TTM)-8.03%
EPS Incl Extra (Annual)$-1.69
Current Ratio (Annual)5.55x
Quick Ratio (Quarterly)2.53x
3-Month Avg Trading Volume0.16M
52-Week Price Return-14.92%
EV / Free Cash Flow (Annual)142.81x
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$10.72
P/S Ratio (Annual)1.91x
Asset Turnover (Annual)0.46x
52-Week High$23.70
Operating Margin (5Y Avg)-18.48%
EPS Excl Extra (Annual)$-1.69
CapEx CAGR (5Y)-0.34%
Tangible BV CAGR (5Y)9.53%
26-Week Price Return-1.38%
Quick Ratio (Annual)2.53x
13-Week Price Return-11.24%
Total Debt / Equity (Annual)0.29x
Current Ratio (Quarterly)5.55x
Enterprise Value$490.365
Revenue / Share Growth (5Y)20.73%
Asset Turnover (TTM)0.48x
Book Value / Share Growth (5Y)2.89%
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)0.51x
Pretax Margin (Annual)-16.58%
Cash / Share (Annual)$2.42
3-Month Return Std Dev46.85%
Gross Margin (5Y Avg)73.90%
Net Income / Employee (TTM)$-0
ROE (Last FY)-11.44%
Net Interest Coverage (Annual)-5.54x
EPS Basic Excl Extra (Annual)$-1.69
Receivables Turnover (TTM)4.91x
Total Debt / Equity (Quarterly)0.29x
EPS Incl Extra (TTM)$-1.69
Receivables Turnover (Annual)4.91x
ROI (TTM)-8.97%
P/S Ratio (TTM)1.91x
Pretax Margin (5Y Avg)-14.44%
Revenue / Share (Annual)$10.07
Tangible BV / Share (Annual)$10.72
Price vs S&P 500 (52W)-44.75%
Year-to-Date Return0.51%
5-Day Price Return11.98%
EPS Normalized (Annual)$-1.69
ROA (5Y Avg)-5.13%
Net Profit Margin (Annual)-16.78%
Month-to-Date Return12.48%
Cash Flow / Share (TTM)$-0.29
EBITD / Share (Annual)$-0.90
Operating Margin (Annual)-16.60%
LT Debt / Equity (Annual)0.29x
ROI (5Y Avg)-6.00%
LT Debt / Equity (Quarterly)0.29x
EPS Basic Excl Extra (TTM)$-1.69
P/TBV (Quarterly)1.66x
P/B Ratio (Annual)1.28x
Inventory Turnover (TTM)0.51x
Pretax Margin (TTM)-16.58%
Book Value / Share (Annual)$13.81
Price vs S&P 500 (13W)-11.93%
Beta1.16x
Revenue / Share (TTM)$10.02
ROE (TTM)-11.34%
52-Week Low$14.91
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.14
4.13
4.13
4.13
Industry Peers — Surgical & Medical Instruments(108)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
KIDSOrthoPediatrics Corp. Common Stock | 1.91x | 27.16% | 73.05% | -16.60% | $16.53 |
SYKStryker Corporation | 5.15x | 11.84% | 64.57% | 19.43% | $338.38 |
BSXBoston Scientific Corp. | 4.76x | 15.16% | 69.01% | 18.00% | $63.42 |
MMM3M Company | 3.18x | -4.97% | 39.92% | 18.55% | $150.55 |
MDLNMedline Inc. Class A common stock | 2.21x | — | 26.44% | 7.78% | $46.94 |
BDXBecton, Dickinson and Co. | 2.01x | 6.32% | 46.42% | 12.15% | $154.82 |
RMDResMed Inc. | 6.06x | 11.72% | 60.85% | 33.70% | $224.72 |
DXCMDexCom, Inc. | 5.23x | 19.33% | 62.09% | 19.56% | $61.23 |
WSTWest Pharmaceutical Services, Inc. | 6.22x | 7.44% | 35.91% | 19.03% | $269.81 |
PODDInsulet Corporation | 5.31x | 24.53% | 71.63% | 12.92% | $201.47 |
PENPenumbra, Inc. | 9.31x | 20.16% | 67.14% | 13.48% | $331.47 |
About
OrthoPediatrics Corp designs and commercializes specialized orthopedic implants and instruments for pediatric patients. The company's product portfolio includes anatomically appropriate devices such as PediLoc, PediPlates, and PediNail systems, as well as ACL reconstruction products. These offerings address the surgical and clinical needs of children with orthopedic conditions.